Pharma distribution in Central Europe in 2011: liberalization of non-pharmacy and on-line sales

20 May 2011

Pharmaceutical distribution has been liberalized further in Central Europe in 2011, with Bulgaria making the on-line sale of medicines legal in March. Non-pharmacy sale of over-the-counter (OTC) medicines may be still allowed in 2011 in Slovakia, which quite recently, ie, in December 2009, liberalized on-line sale of pharmaceuticals.

Conversely, Hungary and Romania have introduced more restrictive rules on the opening of new pharmacies, according to the latest report from Poland-based research and consultancy group PMR, titled Distribution on the pharmaceutical market in Central Europe 2011. Comparative analysis of Poland, Hungary, Romania, the Czech Republic, Slovakia and Bulgaria.

On-line sales allowed in Bulgaria

This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Try before you buy

Free

7 day trial access

Take a Free Trial

All the news that moves the needle in pharma and biotech
Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
Receive The Pharma Letter daily news bulletin, free forever.

Become a subscriber

£820

Or £77 per month

Subscribe Now

Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
Daily roundup of key events in pharma and biotech.
Monthly in-depth briefings on Boardroom appointments and M&A news.
Choose from a cost-effective annual package or a flexible monthly subscription

The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK

More ones to watch >